Discriminant validity of the MASQ in a clinical sample

Author(s): Boschen MJ, Oei TP


A major weakness of the Mood and Anxiety Symptom Questionnaire (MASQ) is that its discriminant validity has not been demonstrated in a clinical population of anxiety and mood disorder patients. This paper, using 470 anxiety and mood disorder patients, assessed the discriminant validity of the MASQ. The MASQ subscales showed statistically significant discriminant validity, but their maximum ability to discriminate is low at 70%. Overall it was concluded that the MASQ had very weak clinical utility in differentiating anxiety and mood disorder patients, and gave rise to doubts as to the tripartite structure of the MASQ. When using the MASQ, future researchers should be mindful of its limitations when applied in a clinical population.

Similar Articles

Self-report and polysomnographic measures of sleep in women with irritable bowel syndrome

Author(s): Heitkemper M, Charman AB, Shaver J, Lentz MJ, Jarrett ME

Hyperarousal and insomnia: state of the science

Author(s): Bonnet MH, Arand DL

Increased urine catecholamines and cortisol in women with irritable bowel syndrome

Author(s): Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, et al.

Salivary alpha-amylase as a measure of endogenous adrenergic activity

Author(s): Chatterton RT Jr, Vogelsong KM, Lu YC, Ellman AB, Hudgens GA

Heart rate variability: standards of measurement, physiological interpretation and clinical use

Author(s): Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

Testing a tripartite model: I

Author(s): Watson D, Weber K, Assenheimer JS, Clark LA, Strauss ME, et al.

The measurement of fatigue: a new instrument

Author(s): Schwartz JE, Jandorf L, Krupp LB

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

Author(s): Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ

Thermoregulation in women

Author(s): Stephenson LA, Kolka MA